Active implantable medical devices - Particular requirements for active implantable medical devices intended to treat tachyarrhythmia (includes implantable defibrillators) Ingestion-build-115288 — the following housings:

— the following housings:

and expression of results with a test report that ensures the testing performance of separation of oil in filling compounds

2  Management of impartiality

BS EN 16571 has been prepared as part of the EU RFID Mandate M/436

Active implantable medical devices - Particular requirements for active implantable medical devices intended to treat tachyarrhythmia (includes implantable defibrillators) Ingestion-build-115288 — the following housings:1 Scope This Part 2 2 of EN 45502 specifies requirements that are applicable to implantable cardioverter defibrillators and the functions of active implantable medical devices intended to treat tachyarrhythmia. The tests that are specified in EN 45502 are type tests and are to be carried out on samples of a device to show compliance. This part of EN 45502 is also applicable to some non implantable parts and accessories of the devices (see Note 1). The